Dual-phase study of CD4+CXCR4+ T cells in Mycoplasma pneumoniae pneumonia: clinical correlations in children and therapeutic exploration with tofacitinib in miceKaiwen Wang, Jiangfeng Zhao, Zhenghan Zhao et al.|Immunobiology|2025Cited by 3
Tofacitinib treats Mycoplasma Pneumoniae Pneumonia by inhibiting the CXCR4 molecule on the CD4+ T lymphocytesKaiwen Wang, Jiangfeng Zhao, Guo Li et al.|Research Square|2025Cited by 0